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Drug Utilization Review 
Backgroutzd: 
One of tile most pressingproblemsfacing public healtll providers and administrotots in many countries is 
ensuring tile rational use of dmgs. 11ze Conference of Experts on the &tional Use of Dmgs, convened by 
tlze World Health Orgatziwtiotz (WHO) in Nairobi uz1985, defitzed ratiotzaluseasfo/Jows: 
1he ratiotzal use of dtugs requires tllat patietzts receive medicatiotzs appropriate to their clitzicalneeds, uz 
doses tlzat meet tlzeir own individual requirements, for atl adequate period of time, mzd at tlze lowest cost to 
them mzd tlzeir communil)l. 
Hospital fonnularies helps optimize tteatmen~ enhance accessibilityto essential drugs and control costs of therapy. The clrugformu. 
lory can be considered the basis of rational drug use. However, the existence of a rationally derived list of drugs approved for pro-
curemenl. and use in a hospital does not ensure thai. they are prescribed and used correctly. One mechanism to ensure correct pre-
scribing and use is the clrug utilization review (DUR) process. 
Definition: 
Drug UtilizationRe-.;ew can be defined as: 
'&•iew of a drug usqge based on tlte basis of a pre•iously estab/islted and appiVl!'ed usqge critsria'-
It may be retrospective. prospective or concurrenl. but the ultimate goal of such exercise is to promote the rational drug us~ by com-
paring actual clruguse to predetermined standards, DUR can detect inappropriate ancllorunnecessarilycostly drugtherapy. Pro~ams 
can be designed to monitor individual drugs or drug classes as well to monitor drug use in specified diseases. When problems are 
identified, interventions are desi~ed and imp! em ented to improve drug use that can include educational programs, pro-,;sion of clrug 
infonnation, changes in hospital policies and procedures, and changes in the clrug formulary. 
Drug Use Criteria: 
Drug use criteria are written documents thai. were carefully constructed with the help of current medical literature regarding a par-
ticular drug It usually consists offollowingfour components: 
• Justificationforuse 
• Crincal Process Indicator 
• Ad•B~S• FJfects 
• Outcomemeasun 
Justificationfor use contains indications, while the critical process indicators routinely describe usual dose range in adult and pediat.-
ric population, laboratory parameters to be checked and/or any precautions related to the administration of a particular clrug. In the 
component of adverse effects,. parameters or statemenl. regarding measuring of adverse effects were gven Outcome measures usu. 
ally estim al.e the beneficial effects or success of the therapy in a particular indication such as resolution of fever as well as chest irfil-
trate are outcome measure of Amoxiciltin/Culavanal.e (Au~ entin) use in a patient withrespiratorytract infection 
